Page last updated: 2024-09-05

3,3',5-triiodothyronamine and natriuretic peptide, brain

3,3',5-triiodothyronamine has been researched along with natriuretic peptide, brain in 1 studies

Compound Research Comparison

Studies
(3,3',5-triiodothyronamine)
Trials
(3,3',5-triiodothyronamine)
Recent Studies (post-2010)
(3,3',5-triiodothyronamine)
Studies
(natriuretic peptide, brain)
Trials
(natriuretic peptide, brain)
Recent Studies (post-2010) (natriuretic peptide, brain)
261816,3171,8678,887

Protein Interaction Comparison

ProteinTaxonomy3,3',5-triiodothyronamine (IC50)natriuretic peptide, brain (IC50)
Atrial natriuretic peptide receptor 1Homo sapiens (human)0.006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gardner, DG; Liang, F; Marimuthu, A; Webb, P; Zhang, S1

Other Studies

1 other study(ies) available for 3,3',5-triiodothyronamine and natriuretic peptide, brain

ArticleYear
Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes.
    The Journal of biological chemistry, 2003, Apr-25, Volume: 278, Issue:17

    Topics: Animals; Animals, Newborn; Cardiomegaly; Drug Synergism; Endothelins; Heart Ventricles; Myocytes, Cardiac; Natriuretic Peptide, Brain; Promoter Regions, Genetic; Rats; Receptors, Thyroid Hormone; Transcription, Genetic; Triiodothyronine; Up-Regulation

2003